information on pertussis.
You can also view a Measles
Webinar for providers
Pertussis in California - The New Normal Recommendations and Resources for Health Care Providers
View the archived
webinar, with audio, in
You can also view the webinar slides as full page
slides or in
In addition, you can review responses to
questions asked by webinar participants.
The live and archived webinar have been approved for
AMA PRA Category 1 Credit™
The webinar was recorded
on 7/23/15. Original release date: 7/28/15.
Review date: 7/22/16. Termination date: 7/23/16
Physicians - to obtain CME, view the webinar and
click here to complete the evaluation and post-test. You must answer at least 5/6
questions correctly to successfully complete the activity for  AMA PRA Category 1 Credit™.
Other health care providers – to obtain a Certificate of Attendance, view the webinar and
click here. Nurses - according to the California
Board of Registered Nursing, Continuing Medical Education is acceptable for meeting RN continuing education requirements, as long as the
course is Category 1, and has been taken within the appropriate time frames. This activity is designated for  AMA PRA Category 1 Credit™
and this is stated on the Certificate of Attendance.
All health care providers are invited to participate in this webinar to learn about
the California pertussis epidemic as well as how to manage pertussis cases and
In 2014, more than 11,000 pertussis cases were reported in California, the highest
number for over 65 years. In this webinar, Kathleen Winter, Epidemiologist in the
Immunization Branch in the California Department of Public Health, will explain
the epidemic, provide an update on pertussis cases in California, describe risk
factors for pertussis and identify those at highest risk for morbidity. Pediatrician
and pertussis expert Dr. James Cherry will discuss the clinical characteristics of
pertussis, and the current recommendations for diagnosis, testing and treatment.
Both experts will discuss frequently asked questions such as the rationale for
vaccinating women during each pregnancy and when a pertussis contact can return
to school or work.
The webinar will close with an open forum for questions from the audience.
This activity is designed for pediatric, internal medicine, family practice, obstetrics and gynecology,
emergency medicine, and urgent care physicians. Other groups who are encouraged to participate include
all primary care health care providers and their office staff who may evaluate a patient presenting
with pertussis-like symptoms.
Upon completion of this activity, participants will be able to:
- List three common clinical characteristics of pertussis
- Identify the laboratory tests that are indicated in patients with suspect pertussis
- Name two appropriate antibiotic regimens to treat pertussis
- State how many days are needed prior to releasing pertussis contacts back to school/work
- State the most important reason why third-trimester pregnant women should receive Tdap
- Explain why pertussis incidence appears to be increasing in California and in the United States
- Describe differences in pertussis morbidity and mortality among infants less than four months of age by race/ethnicity
James D. Cherry, MD, MSc
Dr. Cherry is a Distinguished Research Professor of Pediatrics at the David Geffen School of Medicine
at UCLA and member of the Division of Infectious Diseases at Mattel Children’s Hospital at UCLA.
Dr. Cherry received his medical degree from the University of Vermont in 1957 and his M.Sc.
degree in Epidemiology from the London School of Hygiene and Tropical Medicine in 1983.
He was an intern and resident at Boston City Hospital and Kings County Hospital between
1957 and 1960. He served an Infectious Diseases fellowship at the Thorndike Memorial Laboratory
and the Harvard Medical Service at Boston City Hospital during 1961 and 1962. He has held
faculty positions at the University of Vermont, University of Wisconsin, St. Louis University,
and UCLA extending from 1960 to 2013.
Dr. Cherry‘s primary research focus over the past 30 years has been on vaccines and vaccine-preventable diseases,
with his recent work focusing largely on the epidemiology of Bordetella pertussis and its prevention through new vaccine strategies.
He has received numerous awards, including the Distinguished Physician Award from the Pediatric Infectious Diseases Society in 2003
and the UCLA Medical Alumni Associations’ Medical Science award in 2005.
Kathleen Winter, MPH
Kathleen Winter is an epidemiologist in the Immunization Branch in the California Department of Public Health.
She has worked with the Vaccine-Preventable Diseases Surveillance and Epidemiology Section for the past 9 years
and over that time has closely monitored pertussis disease activity and vaccination efforts.
She has collaborated with the Centers for Disease Control and Prevention
and other partners on several studies contributing to the current understanding of pertussis disease epidemiology
and vaccine effectiveness. Kathleen is also a fourth-year doctoral student at UC Berkeley studying Epidemiology and plans to conduct her dissertation research on pertussis.
The Los Angeles County Department of Public Health is accredited by the Institute for Medical Quality/California
Medical Association (IMQ/CMA) to provide continuing medical education for physicians. The Los Angeles County Department of Public Health designates the live and archived activity for a maximum of
[ 1 ] AMA PRA Category 1 Credit ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This credit may also be applied to the CMA Certification in Continuing Medical Education.
Nurses receive a Certificate of attendance. This
activity is designated for [ 1 ] AMA PRA Category 1 Credit ™ which is recognized by
the California Board of Registered Nursing toward license renewal for registered
For questions or further information, please contact: Disly Juarez, MPH, 213-989-7236,